In January, they were overtaken by Novartis’ Pluvicto and Johnson & Johnson’s Tremfya; last month, it was Novo Nordisk’s Wegovy and J&J’s immunology med that leapfrogged over the previous ...

HYDERABAD, April 7 (Reuters) - Danish drugmaker Novo Nordisk (NOVOb.CO), opens new tab is looking at an early launch of its blockbuster weight-loss drug Wegovy in India to better compete with ...

In this exclusive interview, Business Today speaks with Vikrant Shrotriya, Managing Director of Novo Nordisk India, about the significance of semaglutide (the active ingredient in Wegovy), its ...

Semaglutide is available as Wegovy and Ozempic injections, and also as Rybelsus tablets. The study's findings indicate a potential link between these medications and a lower risk of dementia.

That’ll be four installments of $11. Weight-loss medications like Wegovy? You can pay for the $1,000-plus drug through Affirm. “Buy now, pay later can be translated into pretty much every ...

Novo Nordisk is preparing to launch its blockbuster obesity drug Wegovy (injectable semaglutide) in India later this year, the company told Business Today, setting the stage for a high-stakes ...

Novo Nordisk’s breakneck sales growth has continued in the first quarter of this year with a 24% increase that was helped by a doubling in turnover of obesity blockbuster Wegovy. Group revenues ...

Novo Nordisk's sought-after obesity therapy Wegovy has finally reached the UK and can be prescribed by NHS weight management services – but supplies are being carefully controlled as its ...

on Thursday, March 27, 2025. (AP Photo/Susan Haigh) Updated [hour]:[minute] [AMPM] [timezone], [monthFull] [day], [year] States increasingly struggling to cover the rising cost of popular GLP-1 drugs ...